JPRN-jRCT1080222253未知Unknown
iovel Combination Tablets special drug use surveillance Long-term use in patients with type 2 diabetes mellitus
TAKEDA PHARMACEUTICAL COMPANY LTD.0 个研究点目标入组 3,000 人开始时间: 2013年10月10日最近更新:
试验速览
- 阶段
- Unknown
- 发起方
- 入组人数
- 3,000
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Observational
入排标准
- 年龄范围
- ot applicable 至 ot applicable（—）
- 性别
- All
入选标准
- •Patients with type 2 diabetes mellitus
排除标准
- •Patients meeting any of the following criteria will be excluded:
- •1. Patients with current cardiac failure or a past history of cardiac failure
- •2. Patients with severe ketosis, diabetic coma or precoma, or type 1 diabetes mellitus
- •3. Patients with serious hepatic dysfunction
- •4. Patients with serious renal dysfunction
- •5. Patients with severe infection, pre- or post-operative patients, or patients with serious traumatic injury
- •6. Patients with a history of hypersensitivity to any ingredients of Liovel
- •7. Pregnant or possibly pregnant wome
研究者
相似试验
招募中
不适用
Special drug use Surveillance for EFIENT Tablets- Patient with ischemic cerebrovascular disease with a high risk of ischemic strokeIschemic cerebrovascular disease (associated with large-artery atherosclerosis or small-vessel occluJPRN-jRCT2031220131Matsuoka Yomei1,200
未知
Unknown
Sonias Combination Tablets special drug use surveillance Survey on long-term use in type 2 diabetes mellitusType 2 diabetes mellitusJPRN-jRCT1080222388TAKEDA PHARMACEUTICAL COMPANY LTD.1,000
未知
Unknown
otriga Granular Capsules special drug use surveillance (long-term use survey)HyperlipidemiaJPRN-jRCT1080222407TAKEDA PHARMACEUTICAL COMPANY LTD.3,084
招募中
Unknown
Post-marketing Surveillance Protocol Number;CLCZ696A1402HypertensionJPRN-jRCT2031230283Sugigmoto Toshiya1,000
未知
Unknown
Metact Combination Tablets special drug use surveillance Survey on long-term use for type 2 diabetes mellitusJPRN-jRCT1080222318TAKEDA PHARMACEUTICAL COMPANY LTD.1,000